Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-06 Purchase |
2025-02-12 5:00 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer |
20,000 | $2.2828 | $45,656 | 36,629 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 6:33 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and Interim PFO |
2,615 | $1.7115 | $4,476 | 225,459 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 6:32 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
14,368 | $1.7115 | $24,591 | 637,570 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 6:31 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer |
13,230 | $1.7115 | $22,643 | 1,195,498 (Direct) |
View |
| 2025-01-31 Purchase |
2025-02-04 4:45 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
60,000 | $1.7241 | $103,446 | 149,551 (Direct) |
View |
| 2025-01-31 Purchase |
2025-02-04 4:43 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Walker Luke Nathaniel Director |
14,200 | $1.7582 | $24,966 | 86,681 (Direct) |
View |
| 2025-01-31 Purchase |
2025-02-04 4:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President |
28,500 | $1.7314 | $49,345 | 28,500 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:17 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
4,411 | $3.12 | $13,762 | 191,317 (Direct) |
View |
| 2024-10-04 Sale |
2024-10-04 6:01 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent Principal Accounting Officer |
1,603 | $3.18 | $5,098 | 33,855 (Direct) |
View |
| 2024-05-31 Sale |
2024-05-31 6:27 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President, Interim CFO |
9,597 | $11.98 | $114,972 | 633,680 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-09 7:46 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | HAUSMAN DIANA Chief Medical Officer |
3,356 | $12.62 | $42,353 | 373,876 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 8:22 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
2,573 | $11.44 | $29,435 | 451,449 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 8:21 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
1,173 | $11.44 | $13,419 | 643,277 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:15 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
1,585 | $11.54 | $18,291 | 336,728 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:14 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer |
3,310 | $11.54 | $38,197 | 352,473 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:13 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
11,552 | $11.54 | $133,310 | 836,950 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:12 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
8,669 | $11.54 | $100,040 | 529,022 (Direct) |
View |
| 2023-11-10 Purchase |
2023-11-13 5:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
17,000 | $9.879 | $167,943 | 144,389 (Direct) |
View |
| 2023-11-13 Purchase |
2023-11-13 5:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
5,000 | $10.29 | $51,448 | 254,800 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-06 7:19 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
10,628 | $19.5 | $207,298 | 105,685 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-06 7:19 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
6,068 | $19.5 | $118,355 | 874,439 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-05 6:33 pm |
N/A 2035-02-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and Interim PFO |
194,219 | $0 | 225,459 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 6:32 pm |
N/A 2035-02-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
460,621 | $0 | 637,570 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 6:31 pm |
N/A 2035-02-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer |
1,058,755 | $0 | 1,195,498 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 6:30 pm |
N/A 2035-02-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer |
16,629 | $0 | 33,258 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 6:29 pm |
N/A 2035-02-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President |
59,388 | $0 | 147,276 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-03 7:02 pm |
N/A 2034-12-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer |
712,650 | $0 | 712,650 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-03 7:02 pm |
N/A 2034-12-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President |
3,028,800 | $0 | 3,028,800 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-13 5:46 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director |
260,192 | $0 | 260,192 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:11 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
41,581 | $0 | 89,551 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:09 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director |
41,581 | $0 | 79,762 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:07 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
48,429 | $0 | 192,818 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 07:34 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Walker Luke Nathaniel Director |
72,481 | $0 | 72,481 (Direct) |
View |
Ownership |
2024-04-11 07:02 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent Principal Accounting Officer |
0 | $0 | 110,083 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:16 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | HAUSMAN DIANA Chief Medical Officer |
337,500 | $0 | 714,732 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:15 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
141,000 | $0 | 336,728 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:14 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer |
202,500 | $0 | 352,473 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:13 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
192,500 | $0 | 836,950 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:12 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
75,000 | $0 | 529,022 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:11 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
250,000 | $0 | 734,145 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 7:11 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
20,655 | $11.69 | 734,145 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 8:21 pm |
N/A 2034-01-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
100,000 | $0 | 116,313 (Direct) |
View |
Ownership |
2024-01-03 8:19 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer |
0 | $0 | 255,000 (Direct) |
View |
| 2023-12-20 Gift |
2023-12-21 5:47 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
24,158 | $0 | 850,281 (Direct) |
View |